1. A method of communicating with a wireless station, said method being performed in an access point, said method comprising:
communicating with said wireless station based on a point-to-point channel to determine at a first time instance, a future time instance at or after which a subsequent communication is expected to be received from said wireless station at said access point;
receiving at a second time instance said subsequent communication destined to said access point, wherein said second time instance is at or after said future time instance; and
powering down at least a portion of a circuit contained in said access point in at least a partial duration between said first time instance and said future time instance, to thereby reduce power consumption in said access point.
2. The method of claim 1, further comprising:
creating a data value in said access point; and
transmitting said data value to said wireless station in a duration in which said portion of said circuit is powered on.
3. The method of claim 2, wherein said portion of said circuit comprises a receive block of said access point.
4. The method of claim 3, wherein said wireless station is a mobile phone and said access point is a monitoringcontrolling device.
5. The method of claim 3, wherein said access point is a blood pressure measuring device and said data value represents a magnitude of blood pressure measured on a person wearing said access point.
6. The method of claim 5, wherein said blood pressure measuring device is designed to receive commands indicating a corresponding rate at which said blood pressure is to be measured and transmitted, wherein said subsequent communication is a command, and said future time instance represents a time instance at which said command is expected to be received at said AP.
7. The method of claim 3, wherein each of said access point and said wireless station is designed according to 802.11 standard.
8. A non-transitory computer readable medium storing one or more sequences of instructions for causing an access point to communicate with a wireless station, said one or more sequences of instructions comprising:
a first set of instructions constituting a communication module;
a second set of instructions constituting an application module, wherein execution of said application module causes said access point to perform the actions of:
communicating, based on a communication capability provided by said communication module, with a peer application executing on said wireless station to determine at a first time instance, a future time instance at or after which a subsequent communication is expected to be received from said wireless station at said access point;
receiving at a second time instance said subsequent communication destined to said access point, wherein said second time instance is at or after said future time instance; and
powering down at least a portion of a circuit contained in said access point in at least a partial duration between said first time instance and said future time instance, to thereby reduce power consumption in said access point.
9. The non-transitory computer readable medium of claim 8, wherein execution of said application module further causes said access point to perform the actions of:
creating a data value in said access point; and
transmitting said data value to said wireless station in a duration in which said portion of said circuit is powered on.
10. The non-transitory computer readable medium of claim 9, wherein said portion of said circuit comprises a receive block of said access point.
11. The non-transitory computer readable medium of claim 10, wherein said wireless station is a mobile phone.
12. The non-transitory computer readable medium of claim 10, wherein said access point is a blood pressure measuring device and said data value represents a magnitude of blood pressure measured on a person wearing said access point.
13. The non-transitory computer readable medium of claim 12, wherein said blood pressure measuring device is designed to receive commands indicating a corresponding rate at which said blood pressure is to be measured and transmitted, wherein said subsequent communication is a command, and said future time instance represents a time instance at which said command is expected to be received at said AP.
14. The non-transitory computer readable medium of claim 10, wherein each of said access point and said wireless station is designed according to 802.11 standard.
15. An access point (AP) comprising:
a memory to store instructions;
a processor to retrieve instructions from said memory and to execute said instructions, wherein execution of said retrieved instructions causes said access point to perform the actions of:
communicating with a wireless station based on a point-to-point channel to determine at a first time instance, a future time instance at or after which a subsequent communication is expected to be received from said wireless station at said access point;
receiving at a second time instance said subsequent communication destined to said access point, wherein said second time instance is at or after said future time instance; and
powering down at least a portion of a circuit contained in said access point in at least a partial duration between said first time instance and said future time instance, to thereby reduce power consumption in said access point.
16. The AP of claim 15, wherein execution of said retrieved instructions causes said AP to further perform the actions of:
creating a data value in said access point; and
transmitting said data value to said wireless station in a duration in which said portion of said circuit is powered on.
17. The AP of claim 16, wherein said portion of said circuit comprises a receive block of said access point.
18. The AP of claim 17, wherein said wireless station is a mobile phone and said access point is a monitoringcontrolling device.
19. The AP of claim 17, wherein said access point is a blood pressure measuring device and said data value represents a magnitude of blood pressure measured on a person wearing said access point.
20. The AP of claim 19, wherein said blood pressure measuring device is designed to receive commands indicating a corresponding rate at which said blood pressure is to be measured and transmitted, wherein said subsequent communication is a command, and said future time instance represents a time instance at which said command is expected to be received at said AP.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A topical pharmaceutical composition comprising mupirocin and beclomethasone.
2. The topical pharmaceutical composition according to claim 1, wherein said composition is an ointment, cream, lotion, solution or gel.
3. The topical pharmaceutical composition according to claim 1 or 2, further comprising poly (substituted or unsubstituted alkylene) glycol or a derivative thereof and a pharmaceutically acceptable carrier.
4. The topical pharmaceutical composition according to any of claims 1-3, comprising mupirocin in the range of about 1-5% ww and beclomethasone in the range of about 0.001-1% ww based on the total weight of the composition.
5. The topical pharmaceutical composition according to claim 4, wherein mupirocin content is about 2% ww and beclomethasone content is about 0.025% ww based on the total weight of the composition.
6. The topical composition according to any of the preceding claims, further comprising solvents, vehicles, ointmentcream bases, emulsifiers, preservatives, buffers, emollients, humectants, surfactants, and transport enhancers or mixtures there of.
7. A process for preparing a topical composition comprising:
i) melting and mixing together one or more solid or semi-solid vehicles;
ii) adding mupirocin and beclomethasone to the mixture of step (i) while stirring; and
iii) mixing until the temperature of the composition drops below 40\xb0 C.
8. The process according to claim 7, wherein the one or more solid or semi-solid vehicles comprises poly (substituted or unsubstituted alkylene) glycol or a derivative thereof.
9. Use of mupirocin and beclomethasone in the preparation of a medicament for the treatment of infected dermatoses caused by bacteria susceptible to mupirocin.
10. Use of mupirocin and beclomethasone in the preparation of a medicament for the treatment or prevention of secondary bacterial infections in patients of steroid responsive dermatoses.
11. Use of a pharmaceutical composition according to any of claims 1-6 for the treatment of infected dermatoses caused by bacteria susceptible to mupirocin.
12. Use of a pharmaceutical composition according to any of claims 1-6 for the treatment or prevention of secondary bacterial infections in patients of steroid responsive dermatoses.
13. A method for the treatment of infected dermatoses caused by bacteria susceptible to mupirocin comprising administering an effective amount of a composition comprising mupirocin and beclomethasone.
14. A method for the treatment or prevention of secondary bacterial infections in patients of steroid-responsive dermatoses comprising administering an effective amount of a composition comprising mupirocin and beclomethasone.
15. The method according to claim 13 or 14, wherein the dosage strength of mupirocin is in the range of 1-5% ww, and the dosage strength of beclomethasone is in the range of 0.005-1% ww based on the total weight of the composition.
16. The method according to claim 15, wherein the dosage strength of mupirocin is about 2% ww and the dosage strength of beclomethasone is about 0.025% ww based on the total weight of the composition.